Name: Rob Freishtat

Position: President & Co-Founder of Uncommon Cures

Bio: Dr. Rob Freishtat is a highly regarded physician-executive known for his impact on biotechnology ventures, clinical medicine, and international healthcare initiatives. With a professional history spanning over two decades, Dr. Freishtat has consistently demonstrated his ability to lead high-stakes organizational transformations, drive clinical solutions to the marketplace, and forge strategic global partnerships. As the President and Co-Founder of Uncommon Cures, Dr. Freishtat has transformed clinical trials for rare diseases by implementing a unique trial model that eliminates inefficiencies and accelerates the path to drug approval. Prior to founding Uncommon Cures, Dr. Freishtat was a successful NIH-funded physician-scientist for over 20 years and served in a variety of clinical and research leadership roles. His impact extends to philanthropy, establishing a premier pediatric medical program in Haiti. Dr. Freishtat’s business focus is on innovation, strategic growth, and operational excellence.

Why I’m passionate about patient engagement: “Receiving this award validates my efforts to guide Uncommon Cures toward a vision that prioritizes patient engagement. This award isn’t just a personal milestone—it’s a win for the entire Uncommon Cures team, whose dedication and passion have made our patient-first mission a reality. Being recognized as a thought leader in patient engagement elevates our collective impact and inspires us to continue challenging the status quo. Together, we’re proving that when patients come first, everyone benefits—from research partners to the communities we serve.”